Musclepharm Corp (MSLP) financial statements (2021 and earlier)

Company profile

Business Address 4721 IRONTON STREET
DENVER, CO 80239
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2265716
Cash and cash equivalents2265715
Short-term investments      0
Receivables751713221714
Inventory, net of allowances, customer advances and progress billings1569132116
Inventory1569132116
Prepaid expense  0   3
Derivative instruments and hedges, assets      0
Other current assets      1
Other undisclosed current assets1112685
Total current assets:12123029474645
Noncurrent Assets
Operating lease, right-of-use asset01
Property, plant and equipment0023783
Long-term investments and receivables    1  
Long-term investments    1  
Intangible assets, net (including goodwill)011297
Intangible assets, net (excluding goodwill)011297 
Prepaid expense      5
Deferred costs      0
Other noncurrent assets0000000
Other undisclosed noncurrent assets     5(0)
Total noncurrent assets:123517208
TOTAL ASSETS:13153434646652
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:15312019523528
Accounts payable152612104028 
Accrued liabilities0589137 
Other undisclosed accounts payable and accrued liabilities      28
Debt1110   80
Derivative instruments and hedges, liabilities      1
Restructuring reserve  119 
Other undisclosed current liabilities608196(0)3
Total current liabilities:32422838674332
Noncurrent Liabilities
Long-term debt and lease obligation11170600
Long-term debt, excluding current maturities1 170600
Capital lease obligations0 00 
Operating lease, liability01
Liabilities, other than long-term debt  000  
Restructuring reserve  000  
Other undisclosed noncurrent liabilities4(0)1  (0) 
Total noncurrent liabilities:51181700
Total liabilities:37424639744332
Stockholders' equity
Stockholders' equity attributable to parent, including:(24)(28)(13)(5)(10)2320
Common stock0000000
Treasury stock, value(10)(10)(10)(10)(10)(10)(1)
Additional paid in capital178178160156148129103
Accumulated other comprehensive loss  (0)(0)(0)(0)(0)
Accumulated deficit(193)(196)(162)(151)(148)(96)(82)
Other undisclosed stockholders' equity attributable to parent      0
Total stockholders' equity:(24)(28)(13)(5)(10)2320
TOTAL LIABILITIES AND EQUITY:13153434646652

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues6480102132167177111
Revenue, net102132167177111
Cost of revenue
(Cost of Goods and Services Sold)
(45)(71)(72)(88)(110)(121)(78)
Gross profit:2093044575633
Operating expenses(17)(24)(38)(53)(107)(75)(67)
Other undisclosed operating income      19
Operating income (loss):3(15)(7)(9)(50)(19)(14)
Nonoperating income (expense) 0(5)(2)(2)6(3)
Investment income, nonoperating 0(1)  6(0)
Foreign currency transaction gain (loss), before tax (0)0   (0)
Debt instrument, convertible, beneficial conversion feature   10  
Other nonoperating income (expense)  (4)(2)(2)6(0)
Interest and debt expense1(4)(3)(1) (0) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(0)(0)48(0)0 
Income (loss) from continuing operations before equity method investments, income taxes:3(19)(11)(3)(52)(14)(18)
Other undisclosed loss from continuing operations before income taxes  (0)    
Income (loss) from continuing operations before income taxes:3(19)(11)(3)(52)(14)(18)
Income tax expense (benefit)0(0)0(0)(0)(0)(0)
Net income (loss):3(19)(11)(3)(52)(14)(18)
Other undisclosed net loss attributable to parent  (0)    
Net income (loss) available to common stockholders, diluted:3(19)(11)(3)(52)(14)(18)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):3(19)(11)(3)(52)(14)(18)
Other comprehensive loss      (0)
Comprehensive income (loss):3(19)(11)(3)(52)(14)(18)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (0)(0)0(0)(0) 
Comprehensive income (loss), net of tax, attributable to parent:3(19)(11)(3)(52)(14)(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: